Phosphorothioate oligonucleotides, suramin and heparin inhibit DNA-dependent protein kinase activity. 2002

Y Hosoi, and Y Matsumoto, and M Tomita, and A Enomoto, and A Morita, and K Sakai, and N Umeda, and H-J Zhao, and K Nakagawa, and T Ono, and N Suzuki
Department of Radiation Oncology, Faculty of Medicine, University of Tokyo, Tokyo, Japan. hosoi@m.u-tokyo.ac.jp

Phosphorothioate oligonucleotides and suramin bind to heparin binding proteins including DNA polymerases, and inhibit their functions. In the present study, we report inhibition of DNA-dependent protein kinase activity by phosphorothioate oligonucleotides, suramin and heparin. Inhibitory effect of phosphorothioate oligonucleotides on DNA-dependent protein kinase activity was increased with length and reached a plateau at 36-mer. The base composition of phosphorothioate oligonucleotides did not affect the inhibitory effect. The inhibitory effect by phosphorothioate oligodeoxycytidine 36-mer can be about 200-fold greater than that by the phosphodiester oligodeoxycytidine 36-mer. The inhibitory effect was also observed with purified DNA-dependent protein kinase, which suggests direct interaction between DNA-dependent protein kinase and phosphorothioate oligonucleotides. DNA-dependent protein kinase will have different binding positions for double-stranded DNA and phosphorothioate oligodeoxycytidine 36-mer because they were not competitive in DNA-dependent protein kinase activation. Suramin and heparin inhibited DNA-dependent protein kinase activity with IC(50) of 1.7 microM and 0.27 microg ml(-1) respectively. DNA-dependent protein kinase activities and DNA double-stranded breaks repair in cultured cells were significantly suppressed by the treatment with suramin in vivo. Our present observations suggest that suramin may possibly result in sensitisation of cells to ionising radiation by inactivation of DNA-dependent protein kinase and the impairment of double-stranded breaks repair.

UI MeSH Term Description Entries
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D009841 Oligonucleotides Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed) Oligonucleotide
D011838 Radiation-Sensitizing Agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. Radiation Sensitizer,Radiosensitizing Agent,Radiosensitizing Agents,Agents, Radiation-Sensitizing,Radiation Sensitizers,Radiation Sensitizing Agents,Radiation-Sensitizing Drugs,Radiation-Sensitizing Effect,Radiation-Sensitizing Effects,Radiosensitizing Drugs,Radiosensitizing Effect,Radiosensitizing Effects,Agent, Radiosensitizing,Agents, Radiation Sensitizing,Agents, Radiosensitizing,Drugs, Radiation-Sensitizing,Drugs, Radiosensitizing,Effect, Radiation-Sensitizing,Effect, Radiosensitizing,Effects, Radiation-Sensitizing,Effects, Radiosensitizing,Radiation Sensitizing Drugs,Radiation Sensitizing Effect,Radiation Sensitizing Effects,Sensitizer, Radiation,Sensitizers, Radiation,Sensitizing Agents, Radiation
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005909 Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. Astrocytoma, Grade IV,Giant Cell Glioblastoma,Glioblastoma Multiforme,Astrocytomas, Grade IV,Giant Cell Glioblastomas,Glioblastoma, Giant Cell,Glioblastomas,Glioblastomas, Giant Cell,Grade IV Astrocytoma,Grade IV Astrocytomas
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin

Related Publications

Y Hosoi, and Y Matsumoto, and M Tomita, and A Enomoto, and A Morita, and K Sakai, and N Umeda, and H-J Zhao, and K Nakagawa, and T Ono, and N Suzuki
September 1991, Antiviral research,
Y Hosoi, and Y Matsumoto, and M Tomita, and A Enomoto, and A Morita, and K Sakai, and N Umeda, and H-J Zhao, and K Nakagawa, and T Ono, and N Suzuki
September 1998, Blood,
Y Hosoi, and Y Matsumoto, and M Tomita, and A Enomoto, and A Morita, and K Sakai, and N Umeda, and H-J Zhao, and K Nakagawa, and T Ono, and N Suzuki
January 1991, Experimental cell research,
Y Hosoi, and Y Matsumoto, and M Tomita, and A Enomoto, and A Morita, and K Sakai, and N Umeda, and H-J Zhao, and K Nakagawa, and T Ono, and N Suzuki
June 2001, The Journal of biological chemistry,
Y Hosoi, and Y Matsumoto, and M Tomita, and A Enomoto, and A Morita, and K Sakai, and N Umeda, and H-J Zhao, and K Nakagawa, and T Ono, and N Suzuki
December 2012, Molecular and cellular biochemistry,
Y Hosoi, and Y Matsumoto, and M Tomita, and A Enomoto, and A Morita, and K Sakai, and N Umeda, and H-J Zhao, and K Nakagawa, and T Ono, and N Suzuki
April 2000, Cellular immunology,
Y Hosoi, and Y Matsumoto, and M Tomita, and A Enomoto, and A Morita, and K Sakai, and N Umeda, and H-J Zhao, and K Nakagawa, and T Ono, and N Suzuki
October 1995, Biochemistry and molecular biology international,
Y Hosoi, and Y Matsumoto, and M Tomita, and A Enomoto, and A Morita, and K Sakai, and N Umeda, and H-J Zhao, and K Nakagawa, and T Ono, and N Suzuki
April 2001, Biochemistry,
Y Hosoi, and Y Matsumoto, and M Tomita, and A Enomoto, and A Morita, and K Sakai, and N Umeda, and H-J Zhao, and K Nakagawa, and T Ono, and N Suzuki
May 2016, Nucleic acids research,
Y Hosoi, and Y Matsumoto, and M Tomita, and A Enomoto, and A Morita, and K Sakai, and N Umeda, and H-J Zhao, and K Nakagawa, and T Ono, and N Suzuki
August 2011, Molecules (Basel, Switzerland),
Copied contents to your clipboard!